Market Cap 591.19M
Revenue (ttm) 35.28M
Net Income (ttm) -169.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -479.11%
Debt to Equity Ratio 0.00
Volume 270,300
Avg Vol 266,322
Day's Range N/A - N/A
Shares Out 69.31M
Stochastic %K 81%
Beta 1.47
Analysts Strong Sell
Price Target $24.90

Company Profile

Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase I/II/III clinical trials for the treatment of high nectin-4 expressing tumors; BT5528 (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing t...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 1223 261 503
Address:
Portway Building, Blocks A & B Granta Park Great Abington, Cambridge, United Kingdom
JarvisFlow
JarvisFlow Oct. 3 at 4:43 PM
Needham updates rating for Bicycle Therapeutics ( $BCYC ) to Buy, target set at 30 → 29.
0 · Reply
Fred378
Fred378 Oct. 2 at 2:35 PM
$BCYC long term
0 · Reply
rxptgh
rxptgh Oct. 2 at 12:34 PM
$BCYC very
1 · Reply
kclan
kclan Oct. 1 at 7:22 PM
$BCYC Likey likey!
0 · Reply
highnihilism
highnihilism Oct. 1 at 12:49 PM
$CPK Chesapeake Utilities Trades: 5 | Total $: 3 K | 1.53 × 90-Day Avg $: 1.9 K | Call $: 275 | Put $: 2.7 K | Single-Leg: 60% | Multi-Leg: 40% | Contingent: – $BCYC Bicycle Therapeutics Trades: 3 | Total $: 275 | 0.09 × 90-Day Avg $: 3.2 K | Call $: 275 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $USL United States 12 Month Oil Trades: 5 | Total $: 272 | 0.12 × 90-Day Avg $: 2.2 K | Call $: 272 | Put $: 0 | Single-Leg: 20% | Multi-Leg: 80% | Contingent: – $CVNY Tidal II $CVNA Option Income Strategy ETF Trades: 1 | Total $: 270 | 0.28 × 90-Day Avg $: 949 | Call $: 270 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
rxptgh
rxptgh Sep. 29 at 8:58 PM
$BCYC biotechs have been giving me Nightmares like a dark horse 🐴 But this could be a dark horse with lots of potential
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Sep. 24 at 3:13 PM
$BCYC been awhile since it stuck its head above 7.50 continues up or flattens out back under $7
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Sep. 17 at 3:40 AM
$BCYC what are you guys thinking data before or after oct 31
3 · Reply
eladfff
eladfff Sep. 10 at 9:44 PM
$BCYC Cutting 25% of workforce but increasing board size by 25%. Ok. Nice round numbers anyway. Like this nice round -50% YTD. With green XBI and IBB. Doesn't even include the December Disaster.
0 · Reply
nikitatrades
nikitatrades Sep. 9 at 1:49 PM
$BCYC #BicycleTx's lead drug, zelenectide, shows promising efficacy (45% ORR) & a safer profile vs. PADCEV in bladder cancer, with less neuropathy & skin toxicity. Pivotal Phase II/III data readout & FDA update due Q4. Strong cash position ($700M+) into 2028. 🚴‍♂️🩺 #Biotech
0 · Reply
Latest News on BCYC
Bicycle Therapeutics Is Looking Increasingly Attractive

Aug 20, 2024, 7:37 AM EDT - 1 year ago

Bicycle Therapeutics Is Looking Increasingly Attractive


2 More Potential Biotech Buyout Targets

Mar 25, 2024, 1:07 PM EDT - 1 year ago

2 More Potential Biotech Buyout Targets

AZN BMY EXEL LLY MRK NVS TAK


Bicycle Therapeutics to Host R&D Day on December 14

Nov 30, 2023, 7:00 AM EST - 2 years ago

Bicycle Therapeutics to Host R&D Day on December 14


JarvisFlow
JarvisFlow Oct. 3 at 4:43 PM
Needham updates rating for Bicycle Therapeutics ( $BCYC ) to Buy, target set at 30 → 29.
0 · Reply
Fred378
Fred378 Oct. 2 at 2:35 PM
$BCYC long term
0 · Reply
rxptgh
rxptgh Oct. 2 at 12:34 PM
$BCYC very
1 · Reply
kclan
kclan Oct. 1 at 7:22 PM
$BCYC Likey likey!
0 · Reply
highnihilism
highnihilism Oct. 1 at 12:49 PM
$CPK Chesapeake Utilities Trades: 5 | Total $: 3 K | 1.53 × 90-Day Avg $: 1.9 K | Call $: 275 | Put $: 2.7 K | Single-Leg: 60% | Multi-Leg: 40% | Contingent: – $BCYC Bicycle Therapeutics Trades: 3 | Total $: 275 | 0.09 × 90-Day Avg $: 3.2 K | Call $: 275 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $USL United States 12 Month Oil Trades: 5 | Total $: 272 | 0.12 × 90-Day Avg $: 2.2 K | Call $: 272 | Put $: 0 | Single-Leg: 20% | Multi-Leg: 80% | Contingent: – $CVNY Tidal II $CVNA Option Income Strategy ETF Trades: 1 | Total $: 270 | 0.28 × 90-Day Avg $: 949 | Call $: 270 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
rxptgh
rxptgh Sep. 29 at 8:58 PM
$BCYC biotechs have been giving me Nightmares like a dark horse 🐴 But this could be a dark horse with lots of potential
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Sep. 24 at 3:13 PM
$BCYC been awhile since it stuck its head above 7.50 continues up or flattens out back under $7
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Sep. 17 at 3:40 AM
$BCYC what are you guys thinking data before or after oct 31
3 · Reply
eladfff
eladfff Sep. 10 at 9:44 PM
$BCYC Cutting 25% of workforce but increasing board size by 25%. Ok. Nice round numbers anyway. Like this nice round -50% YTD. With green XBI and IBB. Doesn't even include the December Disaster.
0 · Reply
nikitatrades
nikitatrades Sep. 9 at 1:49 PM
$BCYC #BicycleTx's lead drug, zelenectide, shows promising efficacy (45% ORR) & a safer profile vs. PADCEV in bladder cancer, with less neuropathy & skin toxicity. Pivotal Phase II/III data readout & FDA update due Q4. Strong cash position ($700M+) into 2028. 🚴‍♂️🩺 #Biotech
0 · Reply
bigtuna7
bigtuna7 Sep. 8 at 1:57 PM
$BCYC Looks to be basing, not getting my hopes up.... @SmartestMoney shine some light back on the bike!
1 · Reply
Strangperson
Strangperson Sep. 4 at 4:21 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 12:17 PM
$BCYC Great piece that accurately captures BCYC's current position. So if you want to refresh your understanding of BCYC or learn about BCYC for the first time, this is essential reading. https://beyondspx.com/quote/BCYC/bicycle-therapeutics-pedaling-towards-precision-oncology-with-a-differentiated-platform-nasdaq-bcyc#analysis
0 · Reply
eladfff
eladfff Sep. 2 at 6:36 PM
$BCYC Another $0.50+ fade
0 · Reply
eladfff
eladfff Sep. 2 at 6:35 PM
$BCYC fade through today's AND Friday's gains, ha!
0 · Reply
eladfff
eladfff Aug. 28 at 6:40 PM
$BCYC fades almost every single day. The Daily Fade. Has closed closer to its low than its high 25 of the last 29 sessions
0 · Reply
Stmkr
Stmkr Aug. 28 at 1:45 AM
$BCYC https://pmc.ncbi.nlm.nih.gov/articles/PMC11983102/
0 · Reply
Stmkr
Stmkr Aug. 28 at 1:40 AM
$BCYC Nice to see IONS still actively progressing BCYC molecules for targted delivery of siRNA
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 27 at 6:03 PM
$BCYC reminds me a bit of $QURE different indications/technology, but had decent results and was ignored by the market for the better part of a year had a negative ev for awhile but worked out well for those who rode it out
0 · Reply
Fred378
Fred378 Aug. 26 at 12:29 AM
0 · Reply
eladfff
eladfff Aug. 22 at 7:51 PM
$BCYC Point72 still selling, constant weight pushing down. Sold 2M shares in 2nd Q and had 2M left, probably take the whole 3rd Q before they're done and that selling pressure is relieved. Probably other funds in no rush to help Point72 by putting out big bids
2 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 21 at 12:22 AM
$BCYC https://firstwordpharma.com/story/5921472 bakers bought very large AFTER this data hit in dec shares down over 50% since they bought
0 · Reply